EVE16 Trademark

Trademark Overview

On Tuesday, February 10, 2026, a trademark application was filed for EVE16 with the United States Patent and Trademark Office. The USPTO has given the EVE16 trademark a serial number of 99644627. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 10, 2026. This trademark is owned by InnDura Therapeutics Inc.. The EVE16 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of immunotherapy, cell therapy, gene therapy, and immune cell engineering; biomedical research relating to engineered immune receptors, antibody-dependent cellular cytotoxicity platforms, and targeted immune activation technologies
eve16

General Information

Serial Number99644627
Word MarkEVE16
Filing DateTuesday, February 10, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, February 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch and development in the field of immunotherapy, cell therapy, gene therapy, and immune cell engineering; biomedical research relating to engineered immune receptors, antibody-dependent cellular cytotoxicity platforms, and targeted immune activation technologies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 10, 2026
Primary Code042
First Use Anywhere DateThursday, September 1, 2022
First Use In Commerce DateThursday, June 1, 2023

Trademark Owner History

Party NameInnDura Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, February 10, 2026NEW APPLICATION ENTERED
Tuesday, February 10, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

immune research cell therapy cellular technologies dependent cytotoxicity activation antibody